Citation: | ZHANG Ya, ZHANG Jinlin, ZHAO Shuqiang, YUAN Yaozuo, ZHANG Mei, FAN Xialei, WANG Yalou. Preparation of impurity C of doxycycline hyclate and its evaluation of in vitro antimicrobial activity and toxicity[J]. Journal of China Pharmaceutical University, 2016, 47(4): 463-468. DOI: 10.11665/j.issn.1000-5048.20160412 |
[1] |
Griffin MO, Ceballos G, Villarreal FJ. Tetracycline compounds with non-antimicrobial organ protective properties:possible mechanisms of action[J].Pharm Res,2011, 63:102-107.
|
[2] |
Soni MP,Mahajan MV,Dhumal RV,et al.Genotoxicity evaluation of asymmetric lipid polymer hybrid nanoparticles of doxycycline hydrochloride following intravenous administration[J].Drug Deliv Transl Res,2013, 3(5):421-427.
|
[3] |
Chanta C, Phloenchaiwanit P. Randomized controlled trial of azithromycin versus doxycycline or chloramphenicol for treatment of uncomplicated pediatric scrub typhus[J].J Med Assoc Thai,2015, 98(8):756-760.
|
[4] |
Ruan Y,Han Z,Han X.Report:Clinical curative effect of traditional Chinese medicine combined with doxycycline in the treatment of genital Chlamydia trachomatis and urea plasma urealyticum infections[J].Pak J Pharm Sci,2015, 28(4 Suppl):1555-1557.
|
[5] |
Wang YS,Zhou LM.Bioterrorism-related anthrax and antimicrobial therapy[J].Sichuan J Physiol Sci(四川生理科学杂志),2004;26(3):119-123.
|
[6] |
Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia:part 2(中华人民共和国药典:二部)[S].Beijing:China Medical Science Press,2010:690-692.
|
[7] |
European Pharmacopoeia Commission.European Pharmacopoeia 8.0: volume Ⅱ[S].France:European Directorate for the Quality of Medicines & HealthCare,2014:2110.
|
[8] |
Fisher MW,Hillegas AB,Nazeeri PL.Susceptibility in vitro and in vivo of Pseudomonas pseudomallei to rifampin and tetracyclines[J].Appl Microbiol,1971,22(1):13-16.
|
[9] |
Bryant JE,Brown MP,Gronwall RR,et al.Study of intragastric administration of doxycycline:pharmacokinetics including body fluid,endometrial and minimum inhibitory concentrations[J].Equine Veterin J,2000, 32(3):233-238.
|
[10] |
Li WM,Bao YY,Zhou QX.Degradation pathways and main degradation products of tetracycline antibiotics:research progress[J].Chin J Applied Ecol(应用生态学报),2012, 23(8):2300-2308.
|
[1] | SHAO Shishuai, DUAN Shukang, TIAN Hong, YAO Wenbing, GAO Xiangdong. Design and antitumor activity of programmed cell death ligand 1 epitope peptide vaccine[J]. Journal of China Pharmaceutical University, 2023, 54(2): 245-254. DOI: 10.11665/j.issn.1000-5048.2023022803 |
[2] | CHU Xuxin, BU Fanxue, YIN Tingjie, HUO Meirong. Antitumor strategies based on targeted modulation of tumor-associated macrophages[J]. Journal of China Pharmaceutical University, 2021, 52(3): 261-269. DOI: 10.11665/j.issn.1000-5048.20210301 |
[3] | WANG Tianshuai, YU Junjie, ZHANG Yan, ZENG Jinjin, CUI Jingxin. Advances in platinum-intercalators of DNA as antitumor agents[J]. Journal of China Pharmaceutical University, 2019, 50(5): 505-515. DOI: 10.11665/j.issn.1000-5048.20190501 |
[4] | HE Junjin, WANG Jiayi, HAO Jingchao, CHENG Haoran, XU Hanmei. Antitumor effect of peptide mPEG-SC20k-HM-3 and oxaliplatin combination against human hepatocellular carcinoma SMMC-7721 in nude mice[J]. Journal of China Pharmaceutical University, 2015, 46(4): 476-480. DOI: 10.11665/j.issn.1000-5048.20150415 |
[5] | CHENG Haibo, XU Bin, ZHANG Huibin, ZHOU Jinpei. Synthetic process of antitumor drug dacomitinib[J]. Journal of China Pharmaceutical University, 2014, 45(2): 165-169. DOI: 10.11665/j.issn.1000-5048.20140206 |
[6] | HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105 |
[7] | YANG Yong-fang, YAN Hai-qiang, DING Guo-fang, HUANG Fang-fang. Isolation and purification of an anticancer activity peptide from protein hydrolysate of Mytilus coruscus[J]. Journal of China Pharmaceutical University, 2011, 42(3): 272-275. |
[8] | Research of anti-tumor peptide neutralizing antibodies activities[J]. Journal of China Pharmaceutical University, 2010, 41(2): 171-174. |
[9] | Tumor microenvironment:A novel target for antitumor activity of polysaccharides[J]. Journal of China Pharmaceutical University, 2010, 41(1): 1-10. |
[10] | Studies on the Antitumor Principles of Herba Artemisiae capillaris[J]. Journal of China Pharmaceutical University, 1992, (5): 283-286. |